Celldex Therapeutics Files 8-K on Financials
Ticker: CLDX · Form: 8-K · Filed: Feb 27, 2025 · CIK: 744218
| Field | Detail |
|---|---|
| Company | Celldex Therapeutics, Inc. (CLDX) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Celldex filed an 8-K on Feb 27, 2025, updating on financials. Details TBD.
AI Summary
Celldex Therapeutics, Inc. filed an 8-K on February 27, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing serves as an official update on Celldex Therapeutics' financial status and operational results, which is crucial information for investors and stakeholders to assess the company's performance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting event and does not inherently contain negative or positive news within the provided text.
Key Players & Entities
- Celldex Therapeutics, Inc. (company) — Registrant
- February 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 000-15006 (filing_id) — Commission File Number
- 13-3191702 (tax_id) — I.R.S. Employer Identification No.
- 53 Frontage Road, Suite 220 (address) — Business Address
- Hampton, New Jersey 08827 (address) — Business Address City, State, Zip
FAQ
What specific financial results are being reported by Celldex Therapeutics, Inc. in this 8-K?
The provided text of the 8-K filing does not contain specific financial figures or detailed results of operations. It only indicates that the filing pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is February 27, 2025.
Under which state is Celldex Therapeutics, Inc. incorporated?
Celldex Therapeutics, Inc. is incorporated in Delaware.
What is the Commission File Number for Celldex Therapeutics, Inc.?
The Commission File Number for Celldex Therapeutics, Inc. is 000-15006.
What is the business address of Celldex Therapeutics, Inc. as listed in the filing?
The business address listed is Perryville III Building, 53 Frontage Road, Suite 220, Hampton, New Jersey 08827.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding Celldex Therapeutics, Inc. (CLDX).